Pierre Mozer

3.8k total citations · 1 hit paper
130 papers, 2.4k citations indexed

About

Pierre Mozer is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Urology. According to data from OpenAlex, Pierre Mozer has authored 130 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Pulmonary and Respiratory Medicine, 44 papers in Rheumatology and 41 papers in Urology. Recurrent topics in Pierre Mozer's work include Prostate Cancer Diagnosis and Treatment (60 papers), Prostate Cancer Treatment and Research (34 papers) and Pelvic floor disorders treatments (29 papers). Pierre Mozer is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (60 papers), Prostate Cancer Treatment and Research (34 papers) and Pelvic floor disorders treatments (29 papers). Pierre Mozer collaborates with scholars based in France, United States and Austria. Pierre Mozer's co-authors include Morgan Rouprêt, Raphaële Renard‐Penna, Olivier Cussenot, Éva Compérat, Priscilla Léon, Emmanuel Chartier‐Kastler, Jocelyne Troccaz, Michaël Baumann, Boris Hadaschik and Mark Emberton and has published in prestigious journals such as SHILAP Revista de lepidopterología, Proceedings of the IEEE and Radiology.

In The Last Decade

Pierre Mozer

118 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging–Ultrasound Fusion Targeted Biopsy: A Systematic Review

2014 345 citations Pierre Mozer et al. European Urology profile →

Peers

Countries citing papers authored by Pierre Mozer

Since Specialization

Citations

This map shows the geographic impact of Pierre Mozer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Mozer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Mozer more than expected).

Fields of papers citing papers by Pierre Mozer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Mozer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Mozer. The network helps show where Pierre Mozer may publish in the future.

Co-authorship network of co-authors of Pierre Mozer

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Mozer. A scholar is included among the top collaborators of Pierre Mozer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Mozer. Pierre Mozer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defining ground truth for prostate segmentation of transrectal ultrasound images: Inter‐ and intra‐observer variability of manual versus semi‐automatic methods 2025 ·Medical Physics ·Louis Lenfant, (unknown), Jocelyne Troccaz, G. Fiard, (unknown), Sandrine Voros, Pierre Mozer	1
2	137 - The new artificial urinary sphincter UroActive™ (UroMems): results of the first in man implantation study at 6 months post-activation (SOPHIA study) 2024 ·Continence ·(unknown), Marie‐Aimée Perrouin‐Verbe, (unknown), (unknown), Juliette Cotte, (unknown), (unknown), Pierre Mozer, Emmanuel Chartier‐Kastler	1
3	Comparative effectiveness of robot‐assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy for bladder cancer 2024 ·British Journal of Urology ·(unknown), Ugo Pinar, Louis Lenfant, Jérôme Parra, Christophe Vaessen, Pierre Mozer, (unknown), Morgan Rouprêt, Thomas Seisen	2
4	Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases 2024 ·Nature Reviews Urology ·(unknown), Louis Lenfant, Ugo Pinar, Jérôme Parra, Pierre Mozer, Raphaële Renard‐Penna, Constance Thibault, Morgan Rouprêt, Thomas Seisen	5
5	Perioperative and functionnal outcomes of robot-assisted laparoscopic versus open ureterovesical reimplantation for benign lower ureteral pathologies: a single-center comparative study 2024 ·World Journal of Urology ·(unknown), Ugo Pinar, Louis Lenfant, Jérôme Parra, Christophe Vaessen, Sarah Drouin, Pierre Mozer, (unknown), Emmanuel Chartier‐Kastler, Morgan Rouprêt, Thomas Seisen	0
6	Courbes d’apprentissage de la biopsie ciblée de fusion et de la segmentation échographique de la prostate : une étude monocentrique incluant 14 opérateurs et 1721 patients 2023 ·Louis Lenfant, (unknown), Jocelyne Troccaz, Sandrine Voros, (unknown), Morgan Rouprêt, Pierre Mozer	1
7	Robot-assisted Periprostatic Artificial Urinary Sphincter Implantation in Men with Neurogenic Stress Urinary Incontinence: Description of the Surgical Technique and Comparison of Long-term Functional Outcomes with the Open Approach 2023 ·European Urology ·Edward H. Lambert, Emmanuel Chartier‐Kastler, Christophe Vaessen, (unknown), Juliette Cotte, Morgan Rouprêt, Pierre Mozer, Jérôme Parra, Thomas Seisen, Louis Lenfant	3
8	Ureteropelvic junction obstruction and renal calculi: Simultaneous treatment by robot-assisted laparoscopic pyeloplasty and transcutaneous retrograde flexible ureteroscopy. Technique description and early outcomes 2023 ·Progrès en Urologie ·Gregor Krings, (unknown), Riccardo Campi, Morgan Rouprêt, Christophe Vaessen, (unknown), Pierre Mozer	1
9	Long‐term device survival after a first implantation of AMS800™ for stress urinary incontinence: Comparison between men and women 2022 ·Neurourology and Urodynamics ·Juliette Cotte, Agnès Dechartres, Pierre Mozer, (unknown), Emmanuel Chartier‐Kastler, (unknown)	2
10	Transition zone and anterior stromal prostate cancers: Evaluation of discriminant location criteria using multiparametric fusion-guided biopsy 2018 ·Diagnostic and Interventional Imaging ·(unknown), Pierre Mozer, Morgan Rouprêt, Éva Compérat, François Rozet, É. Barret, Sarah Drouin, Christophe Vaessen, Olivier Lucidarme, Olivier Cussenot, (unknown), Raphaële Renard‐Penna	5
11	Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy 2016 ·World Journal of Urology ·(unknown), Géraldine Cancel‐Tassin, Éva Compérat, Pierre Mozer, Priscilla Léon, Justine Varinot, Morgan Rouprêt, Marc‐Olivier Bitker, Olivier Lucidarme, Olivier Cussenot	14
12	First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer 2015 ·HAL (Le Centre pour la Communication Scientifique Directe) ·Pierre Mozer, Morgan Rouprêt, Chloé Le Cossec, Benjamin Granger, Éva Compérat, (unknown), Olivier Cussenot, Raphaële Renard‐Penna	4
13	Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer 2015 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Thomas Seisen, Olivier Cussenot, Sarah Drouin, Susanna Cattarino, Éva Compérat, Raphaële Renard‐Penna, Pierre Mozer, Marc‐Olivier Bitker, Morgan Rouprêt	30
14	Imagerie de diffusion comme marqueur non invasif de l’agressivité du cancer de prostate : comparaison aux marqueurs biologiques, histologiques, immuno-histochimiques et moléculaires 2015 ·Progrès en Urologie ·R. Renard-Penna, Géraldine Cancel‐Tassin, Éva Compérat, P. González, Morgan Rouprêt, Pierre Mozer, M.O. Bitker, Olivier Cussenot	1
15	First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography‐guided biopsies for the diagnosis of localised prostate cancer 2014 ·British Journal of Urology ·Pierre Mozer, Morgan Rouprêt, Chloé Le Cossec, Benjamin Granger, Éva Compérat, (unknown), Olivier Cussenot, Raphaële Renard‐Penna	121
16	Comparison of oncologic outcomes after radical prostatectomy in men diagnosed with prostate cancer with PSA levels below and above 4 ng/mL 2013 ·World Journal of Urology ·Charles Dariane, Chloé Le Cossec, Sarah Drouin, (unknown), Benjamin Granger, Pierre Mozer, Marc‐Olivier Bitker, Shahrokh F. Shariat, Olivier Cussenot, Morgan Rouprêt	3
17	Long-term Functional Outcomes After Ileal Ureter Substitution: A Single-center Experience 2011 ·Urology ·(unknown), Emmanuel Chartier‐Kastler, Pierre Mozer, A Haertig, Marc‐Olivier Bitker, Morgan Rouprêt	48
18	Chapitre H - Les conséquences neuro-urologiques de la chirurgie de l’incontinence urinaire d’effort et de la statique pelvienne 2007 ·Progrès en Urologie ·Emmanuel Chartier‐Kastler, N. Ayoub, Pierre Mozer, François Richard, A. Ruffion	0
19	Chapitre G - Les conséquences neuro-urologiques de la chirurgie gynécologique (endométriose, hystérectomie simple, colpo-hystérectomie élargie), de la chirurgie colo-rectale et de la radiothérapie pelvienne 2007 ·Progrès en Urologie ·(unknown), Pierre Mozer, E. Chartier-Kästler, A. Ruffion	8
20	Chapitre A-3 - Lithiase du haut appareil et vessie neurologique: spécificités thérapeutiques 2007 ·Progrès en Urologie ·Pierre Mozer, E. Chartier-Kästler, A. Ruffion	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact